You are currently viewing Percutaneous Mechanical Circulatory Support Devices Market Growth Outlook From $2.7 Billion In 2026 To $3.87 Billion By 2030
Percutaneous Mechanical Circulatory Support Devices Market Analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Percutaneous Mechanical Circulatory Support Devices Market Poised To Hit $3.87 Billion By 2030 With A 9.4% CAGR#_x000D_

The percutaneous mechanical circulatory support devices market has shown significant expansion in recent years. This market is anticipated to expand from $2.46 billion in 2025 to $2.7 billion in 2026, registering a compound annual growth rate (CAGR) of 9.7%. The historical growth of this market can be linked to several factors, including the rising cardiovascular disease burden, increasing cardiogenic shock cases, adoption of minimally invasive procedures, ICU care expansion, and an aging population._x000D_

_x000D_

The percutaneous mechanical circulatory support devices market is projected to experience robust growth in the upcoming years. This market is anticipated to expand to $3.87 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. The expansion during the forecast period is attributable to AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the broadening of cath lab procedures, the demand for temporary heart support, and innovations in advanced pump technologies. Significant trends for this period include minimally invasive cardiac support, short-term hemodynamic assistance, high-risk PCI support devices, rapid deployment cardiac systems, and designs focused on enhanced patient safety._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=21645547&type=smp&name=Percutaneous%20Mechanical%20Circulatory%20Support%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Percutaneous Mechanical Circulatory Support Devices Market Growth Factors: What’s Supporting Expansion?#_x000D_

The rising occurrence of cardiovascular diseases is anticipated to advance the expansion of the percutaneous mechanical circulatory support devices market in the future. Cardiovascular diseases, also known as CVDs, encompass a collection of ailments that impact the heart and blood vessels, such as coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. The growing prevalence of these conditions stems from contributing factors like an aging population, detrimental lifestyle choices, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices find application in cardiovascular diseases to enhance cardiac function, alleviate strain on the heart, and aid recovery in severe cardiac situations. For instance, in October 2024, data from the Centers for Disease Control and Prevention, a US-based public health institute, indicated that in 2023, approximately 1 out of every 6 deaths resulting from cardiovascular diseases occurred in adults younger than 65 years old, and a total of 919,032 people succumbed to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the escalating incidence of cardiovascular diseases is fueling the growth of the percutaneous mechanical circulatory support (MCS) devices market._x000D_

_x000D_

#Percutaneous Mechanical Circulatory Support Devices Market Segmentation And Category Overview#_x000D_

The percutaneous mechanical circulatory support devices market covered in this report is segmented – _x000D_

_x000D_

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types_x000D_

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications_x000D_

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices _x000D_

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power) _x000D_

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO) _x000D_

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System _x000D_

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices _x000D_

_x000D_

_x000D_

#Percutaneous Mechanical Circulatory Support Devices Market Industry Trends: What’s Reshaping Demand?#_x000D_

Major companies operating within the percutaneous mechanical circulatory support devices market are concentrating on developing technologically advanced solutions, including intra-aortic axial-flow devices, to improve patient outcomes and reduce surgical risks. An intra-aortic axial-flow device is a type of percutaneous mechanical circulatory support (MCS) device specifically engineered to assist heart function by increasing blood flow from the left ventricle to the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device company, reported the successful first-in-human use of its Aortix pump. This innovative device aims to prevent acute kidney injury (AKI) in patients undergoing cardiac surgery. Delivered via a catheter in the descending thoracic aorta, the Aortix pump works by improving renal perfusion while simultaneously reducing the heart’s workload during surgery. It achieves this by enhancing both renal and systemic perfusion while decreasing the strain on the heart, making it particularly advantageous for individuals with compromised left ventricular function and renal impairment. Capable of delivering up to 5.0 liters of flow per minute, the Aortix pump is designed for temporary use during procedures such as percutaneous coronary interventions (PCI)._x000D_

_x000D_

#Percutaneous Mechanical Circulatory Support Devices Market Competitive Landscape: Who Leads The Industry?#_x000D_

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc. _x000D_

_x000D_

#View The Full Percutaneous Mechanical Circulatory Support Devices Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Percutaneous Mechanical Circulatory Support Devices Market Geographic Landscape: Which Region Leads Industry Growth?#_x000D_

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model